Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 56

Results For "SPI"

3170 News Found

Sun's cancer drug shines delivering 50% response rate with long-lasting tumor control
Clinical Trials | May 27, 2026

Sun's cancer drug shines delivering 50% response rate with long-lasting tumor control

These data support clinically meaningful efficacy within this patient population. We observed a high rate of complete responses in patients with laCSCC


President of India confers Padma Shri Award on Dr. P. Vijay Anand Reddy
Hospitals | May 26, 2026

President of India confers Padma Shri Award on Dr. P. Vijay Anand Reddy

The director of Apollo Cancer Centres in Hyderabad and founder of CURE Foundation honored for his contributions to cancer awareness and treatment


HealthTech future will be defined by partnerships grounded in trust: Dr. Sabine Kapasi, CEO, Enira Consulting and Founder of ROPAN Healthcare
Opinion | May 26, 2026

HealthTech future will be defined by partnerships grounded in trust: Dr. Sabine Kapasi, CEO, Enira Consulting and Founder of ROPAN Healthcare

India already has talent, digital infrastructure, entrepreneurial energy, clinical expertise, and policy momentum. The next phase demands coordinated execution and building institutions that can hold the ecosystem together over time


Cornerstone Robotics secures EU CE mark and Singapore HSA approval for Sentire Surgical System
Medical Device | May 26, 2026

Cornerstone Robotics secures EU CE mark and Singapore HSA approval for Sentire Surgical System

Dual regulatory clearances for Sentire(R) Endoscopic surgical system strengthen the company’s expansion across Europe and Asia-Pacific in minimally invasive robotic surgery


Lilly posts strong early clinical results for one-shot gene-editing cholesterol therapy
Clinical Trials | May 26, 2026

Lilly posts strong early clinical results for one-shot gene-editing cholesterol therapy

A one-shot gene-editing cholesterol therapy could soon be a reality


China greenlights Boehringer Ingelheim’s HERNEXEOS for aggressive lung cancer
Drug Approval | May 26, 2026

China greenlights Boehringer Ingelheim’s HERNEXEOS for aggressive lung cancer

The decision clears the drug as a monotherapy for adults with unresectable, locally advanced or metastatic non-small cell lung cancer


AbbVie scores key EU backing for Hepatitis C drug in push for earlier treatment
News | May 25, 2026

AbbVie scores key EU backing for Hepatitis C drug in push for earlier treatment

If cleared, MAVIRET would become one of the few therapies in the European Union approved to treat both acute and chronic hepatitis C infections


SMS Pharma posts 48% profit surge in FY26 as margins expand & portfolio shift drives growth
News | May 25, 2026

SMS Pharma posts 48% profit surge in FY26 as margins expand & portfolio shift drives growth

Revenue from operations climbed 13% to Rs. 886.87 crore


AstraZeneca to showcase cancer pipeline push at ASCO 2026
R&D | May 25, 2026

AstraZeneca to showcase cancer pipeline push at ASCO 2026

Across more than 85 abstracts, AstraZeneca will showcase 10 approved medicines and 13 potential new therapies


Maxivision appoints Surya K as Group Head – Medical Affairs and Quality
People | May 23, 2026

Maxivision appoints Surya K as Group Head – Medical Affairs and Quality

Surya to lead medical governance, patient safety, clinical excellence, and quality assurance initiatives across the organization’s pan-India network.